Filtered By:
Nutrition: Organic
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 304 results found since Jan 2013.
Air pollution and headache disorders
Divyani Garg, Man Mohan Mehndiratta, Mohammad Wasay, Vasundhara AggarwalAnnals of Indian Academy of Neurology 2022 25(7):35-40
Air pollution, the most prevalent form of pollution worldwide, is associated with a wide range of neurological disorders, including neurodegenerative conditions, stroke, autism, depression, and developmental delay. There is accumulating evidence on the association between air pollution and headache disorders, especially migraine. Many classical and non-classical air pollutants have been associated with headache, including particulate matter, nitrogen dioxide, sulfur dioxide, ozone, carbon monoxide...
Source: Annals of Indian Academy of Neurology - September 7, 2022 Category: Neurology Authors: Divyani Garg Man Mohan Mehndiratta Mohammad Wasay Vasundhara Aggarwal Source Type: research
independent origin for M.3243A & gt;G mitochondrial mutation in three venezuelan cases of melas syndrome
Clin Biochem. 2022 Sep 18:S0009-9120(22)00221-1. doi: 10.1016/j.clinbiochem.2022.09.007. Online ahead of print.ABSTRACTMitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a multisystem and progressive neurodegenerative mitochondrial disease, caused by point nucleotide changes in the mtDNA where 80% of cases have the mutation m.3243A>G in the MT-TL1 gene. In this work, we described the clinical, biochemical and molecular analysis of three Venezuelan patients affected with MELAS syndrome. All cases showed lactic acidosis, cortical cerebral atrophy on magnetic resonance imaging and ...
Source: Clinical Biochemistry - September 21, 2022 Category: Biochemistry Authors: Ingrid Florez Irune Pirrone Liliana Casique Carmen Luisa Dom ínguez Antonieta Mahfoud Tania Rodr íguez Daniel Rodr íguez Marisel De Lucca Jos é Luis Ramírez Source Type: research
Intervention for suicidal behavior in a patient with poststroke depression: a successful case report - Li M, Xie HZ, Jiang C, Luo Q, Ji YG, Zhu WJ, Chen HY, Huang XY, Yang ZQ, Li F, Chen K.
Poststroke Depression (PSD) is an organic mood disorder that is a type of emotional disorder (Starkstein& Hayhow, 2019). The prevalence rate of PSD ranges from 25% to 80% (Andersen et al. 1996). Approximately 20-79% of stroke patients were diagnosed with ...
Source: SafetyLit - October 24, 2022 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
AbstractAngiogenesis is a vital biological process involving blood vessels forming from pre-existing vascular systems. This process contributes to various physiological activities, including embryonic development, hair growth, ovulation, menstruation, and the repair and regeneration of damaged tissue. On the other hand, it is essential in treating a wide range of pathological diseases, such as cardiovascular and ischemic diseases, rheumatoid arthritis, malignancies, ophthalmic and retinal diseases, and other chronic conditions. These diseases and disorders are frequently treated by regulating angiogenesis by utilizing a va...
Source: European Journal of Medical Research - November 4, 2022 Category: Research Source Type: research
Screening for obstructive sleep apnoea in high-risk patients with mood disorders
CONCLUSIONS: This pilot study showed an increased risk of OSA in patients with mood disorders. Psychiatric patients with identified risk factors should be routinely screened for obstructive sleep apnoea and referred to proper treatment.PMID:36528884
Source: Neuroendocrinology Letters - December 18, 2022 Category: Endocrinology Source Type: research
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
